OncoHealth

Oncology costs are climbing fast, and traditional management models may no longer be enough. At AMCP 2026, Beth Isaac, Kelly Romo (Procailo), and Adam Hoye-Simek, shared perspectives on why the future of oncology management will require more coordinated, clinically informed approaches across the full continuum of cancer care. Read more in this latest article from AJMC: https://lnkd.in/gWCrVmhT

In oncology, expertise matters. So does advocacy. This Nurses Appreciation Week, we’re proud to recognize Tori, a Medical Oncology Nurse at OncoHealth.   As part of our utilization management team, Tori reviews treatment plans to help ensure patients can access the care they need. While her work may not always be visible, its impact is felt in critical moments, when clinical expertise helps guide the right decision for each patient.   Her path to nursing started early, caring for her great grandmother alongside her family. That experience sparked a lifelong commitment to helping others, one that continues to shape her work today.   Like many in oncology, her career didn’t start in this specialty, but once she found it, she never looked back. “Oncology is truly a special field. We have the privilege of helping care for people through some of the hardest times of their lives.”   In her role, Tori brings both clinical judgment and thoughtful consideration to every case. Because in oncology, no two patients are the same, and sometimes the most important decisions are the ones that don’t fit the mold, but best serve the individual.   At OncoHealth, it’s this combination of expertise and advocacy that helps us better support members and health plans navigating the complexities of cancer care.   Thank you, Tori, for the impact you make every day.

In oncology, expertise matters. So does compassion. This Nurses Appreciation Week, we’re proud to recognize Laura, a Senior Oncology Nurse at OncoHealth, whose work reflects both.   Laura reviews prior authorization requests across chemotherapy, supportive care, and radiation, helping ensure patients receive timely, appropriate treatment. Behind the scenes, her role plays a critical part in reducing delays and supporting better outcomes.   But like so many oncology nurses, her impact goes far beyond clinical review.   Early in her career, Laura cared for a patient close to her own age who was nearing end of life. Supporting her in preserving memories for her young children became one of the most meaningful experiences of her career, and a lasting reminder of the responsibility and privilege that comes with oncology care.   “Advocacy in oncology comes in many shapes and sizes. It requires strong clinical judgment, but also a human approach to support patients and families through incredibly difficult moments.”   At OncoHealth, it’s this combination of clinical expertise and compassion that helps us better support members and health plans navigating the complexities of cancer care.   Thank you, Laura, for the impact you make every day.

Be sure to add this session to your calendar! This is a great opportunity to learn how the oncology community is advancing more efficient, standards-based approaches to prior authorization, helping improve access and outcomes in cancer care. Excited to have our Chief Medical Officer, Andrew Norden, MD, as part of the discussion.

The bladder cancer treatment landscape is evolving rapidly, bringing both opportunity and complexity for managed care. https://lnkd.in/e4Bf__XA   From emerging bladder-sparing gene therapies in NMIBC to new perioperative combinations in MIBC, innovation is expanding options for patients while raising critical questions around: 🔹 Patient selection 🔹 Durability of response 🔹 Total cost of care 🔹 Toxicity of treatment   As more therapies enter an already crowded space, the absence of head-to-head data will make coverage and treatment decisions increasingly challenging.   In our latest expert analysis, we break down what these advancements mean for managed care and how plans can prepare. Read full analysis: https://lnkd.in/e4Bf__XA

Great conversations at #AMCP2026 last week! As oncology innovation accelerates, especially with the rise of precision therapies and specialty drugs, it’s putting even more pressure on managed care to stay ahead. If you missed our session, you can explore related insights in this overview of 6 pivotal drug approvals to watch in 2026. Take a look: https://lnkd.in/dAPP9rwR

Great conversations, great energy, and even better insights at #AMCP2026 this week! We loved connecting with so many of you at our Happy Hour, and a big thank you to everyone who joined the session on Rethinking Oncology Management. It’s clear there’s real momentum across the industry to evolve how we approach cost, care, and access in oncology. Excited to keep the conversation going!

#AMCP2026 has been full of valuable insights so far! Looking forward to tomorrow where Beth Isaac, Adam Hoye-Simek, and Kelly Romo (Procailo) will be sharing their perspectives on rethinking oncology management, an important conversation at the intersection of clinical quality, cost, and care coordination. See you there!

#AMCP2026 has arrived! Connect with us at our Happy Hour this Wednesday. RSVP to save your spot: https://lnkd.in/gXrBkRZZ Looking forward to seeing you there!

Ready for #AMCP2026 next week? Don’t miss Beth Isaac, SVP of Clinical Success and Strategy at OncoHealth, as she explores evolving challenges in oncology management and how health plans can better navigate rising complexity, cost, and innovation. Learn more about the session: https://cdmcd.co/Ed9Kvy